Related by context. Frequent words. (Click for all words.) 76 Panzem R 75 2 methoxyestradiol 72 Lubiprostone 72 peripherally acting 72 Inhalation Aerosol 71 candidate Zenvia 71 Receives Orphan Drug Designation 71 Meets Primary Endpoint 71 pseudobulbar affect PBA 70 Dapagliflozin 70 R sorafenib tablets 70 FACTIVE R gemifloxacin 70 inhaled formulation 70 refractory chronic lymphocytic 70 Coadministration 70 liposomal formulation 69 Belimumab 69 topical non steroidal 69 sodium Injection 69 investigational mTOR inhibitor 69 Surgical Adhesive 69 Ferumoxytol 69 dipropionate 69 Vytorin combines 69 Onalta 69 BYETTA ® 69 antiplatelet agent 69 Eculizumab 69 Rivaroxaban 68 Kuvan R 68 angiotensin receptor blocker ARB 68 Generic Version 68 Injectable Suspension 68 Release Tablets 68 6R BH4 68 phenylketonuria PKU developed 68 HMG CoA reductase inhibitors 68 Nexavar ® 68 non alcoholic steatohepatitis 68 products Oncaspar 68 Epratuzumab 68 Potassium Chloride Sodium Ascorbate 68 Inhalation Solution 68 Genasense ® oblimersen 68 Recombinant Human 68 mesylate 68 proteasome inhibitor 68 Fortical R 67 Initiates Phase II 67 BioGlue R 67 Sodium oxybate 67 Copegus R 67 anticancer compound 67 MKC# 67 Ambrisentan 67 SIMCOR 67 Alinia 67 Single Dose 67 Oral Suspension Oral Suspension 67 CHEAP ONLINE PHARMACY LOW 67 injection USP 67 Ticagrelor 67 Boceprevir 67 angiotensin II receptor blocker 67 Noxafil 67 VEGFR2 inhibitor 67 fibrosis IPF 67 Eltrombopag 67 FDA Accepts 67 Completes Enrollment 67 inflammatory autoimmune diseases 67 gets USFDA nod 66 dermal patch 66 Racivir 66 mTOR inhibitor 66 Fenofibrate 66 Phase III Clinical Trial 66 Vaprisol 66 Acetate Rectal Suppositories 66 Gemzar ® 66 fumarate 66 Study Evaluating 66 secondary hyperparathyroidism 66 Ciclesonide 66 ® bortezomib 66 J Am Coll 66 ABILIFY R 66 Currently RegeneRx 66 candidate AP# 66 Locteron ® 66 Mipomersen 66 Sapacitabine 66 Xanafide 66 Daclizumab 66 fluoroquinolone class 66 Tacrolimus 66 phenylketonuria PKU 66 Nonsteroidal anti inflammatory 66 Calcitonin 66 Drug Candidate 66 VALSTAR